|
Aug 28
|
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
|
|
Aug 28
|
Warren Buffett Bets His Fortune On One Of 9 'Can't Lose' Stocks
|
|
Aug 28
|
Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.
|
|
Aug 27
|
Ken Fisher’s Top 15 Growth Stock Picks
|
|
Aug 5
|
3 Fantastic Growth Stocks to Buy in August
|
|
Aug 4
|
Ozempic Is the Rage. Why That May Explain a Mysterious Medtech Stock Selloff.
|
|
Aug 4
|
Allurion sees tailwind from weight loss drug frenzy
|
|
Aug 4
|
Eli Lilly Stock Is on a Tear. Expect More Gains After Earnings.
|
|
Aug 4
|
Palantir Stock Holds Near Highs Ahead Of Q2 Results; Fast-Growing Celsius Battles Near Key Support Level
|
|
Aug 4
|
Beat the Dow Jones With This Unstoppable Dividend Stock
|
|
Aug 4
|
Lilly's Retevmo® (selpercatinib) is the First Targeted Therapy to Demonstrate Superior Progression-Free Survival Compared to a PD-1 Inhibitor Plus Chemotherapy for Adults with Newly-Diagnosed Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lu...
|
|
Aug 4
|
12 Best Biotech ETFs To Buy
|
|
Aug 2
|
Eli Lilly (LLY) to Report Q2 Earnings: What's in the Cards?
|
|
Aug 2
|
Ozempic Could Have a New Multibillion-Dollar Market Opportunity. Is Novo Nordisk Stock a No-Brainer Buy?
|
|
Aug 1
|
Merck (MRK) Reports Q2 Loss, Tops Revenue Estimates
|
|
Jul 31
|
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
|
|
Jul 31
|
INSIGHT-Promising new Alzheimer's drugs may benefit whites more than Blacks
|
|
Jul 30
|
Booming Demand Boosts Forecasts for Weight-Loss Drugs
|
|
Jul 28
|
10 Best Small Cap Pharma Stocks to Buy
|
|
Jul 28
|
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Results, MRK, MRNA Cancer Jab in Phase III
|